Dolutegravir is approved for use in a broad population of
It can be used to
treat HIV-infected adults who have never taken HIV therapy (treatment-naïve)
and HIV-infected adults who have previously taken HIV therapy
(treatment-experienced), including those who have been treated with other
integrase strand transfer inhibitors.
All Rights Reserved 2015-2020 Xiamen Halosyntech Co., Ltd 闽ICP备15020441号-1
Tel：0592-6688068 Address: Unit 404/block5，120 Xinyuan RD，Haicang District,Xiamen，PRC